Atlas Global Brands (XCNQ:ATL) Debt-to-EBITDA : -2.00 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Atlas Global Brands Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Atlas Global Brands's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$21.46 Mil. Atlas Global Brands's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$1.72 Mil. Atlas Global Brands's annualized EBITDA for the quarter that ended in Dec. 2023 was C$-11.59 Mil. Atlas Global Brands's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -2.00.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Atlas Global Brands's Debt-to-EBITDA or its related term are showing as below:

XCNQ:ATL' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0 Med: 0 Max: 4.17
Current: 4.17

During the past 0 years, the highest Debt-to-EBITDA Ratio of Atlas Global Brands was 4.17. The lowest was 0.00. And the median was 0.00.

XCNQ:ATL's Debt-to-EBITDA is not ranked
in the Drug Manufacturers industry.
Industry Median: 1.67 vs XCNQ:ATL: 4.17

Atlas Global Brands Debt-to-EBITDA Historical Data

The historical data trend for Atlas Global Brands's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atlas Global Brands Debt-to-EBITDA Chart

Atlas Global Brands Annual Data

Trend

Debt-to-EBITDA

Atlas Global Brands Quarterly Data
	Dec22	Jun23	Sep23	Dec23
Debt-to-EBITDA	-	0.62	-5.76	-2.00

Competitive Comparison of Atlas Global Brands's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Atlas Global Brands's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Atlas Global Brands's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Atlas Global Brands's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Atlas Global Brands's Debt-to-EBITDA falls into.

Atlas Global Brands Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Atlas Global Brands's Debt-to-EBITDA for the fiscal year that ended in . 20 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(	+	)	/	N/A
	=	N/A

Atlas Global Brands's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(21.456	+	1.715)	/	-11.592
	=	-2.00

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.

Atlas Global Brands (XCNQ:ATL) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Atlas Global Brands Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Atlas Global Brands's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Atlas Global Brands (XCNQ:ATL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Atlas Global Brands Inc (XCNQ:ATL) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

566 Riverview Drive, Unit 104, Chatham, ON, CAN, N7M 0N2

Website

Atlas Global Brands Inc is a licensed cannabis company operating in Canada and Israel with experience across the cannabis value chain including cultivation, manufacturing, scalability, marketing, distribution, and pharmacy. Atlas currently serves eight countries: Australia, Canada, Denmark, Germany, Israel, Norway, Spain, and the United Kingdom.

Executives

Tamir Gedo	10% Security Holder
Jonathan Ben-cnaan	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Bernard Yeung	Senior Officer
Jason Cervi	Senior Officer
Jeffrey Robert Gossain	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6), Senior Officer

Atlas Global Brands (XCNQ:ATL) Headlines

No Headlines